-+ 0.00%
-+ 0.00%
-+ 0.00%

Bausch Health's Guided Slowdown Arrives With the Credibility of Its Raised Outlook on the Line

Barchart·10/27/2026 16:03:48
Listen to the news
Barchart +8.41% Beat Dec 2025 $1.21 $1.08 -10.74% Miss Mar 2026 $0.81 $0.78 -3.70% Miss Jun 2026 $0.96 $1.26 +31.25% Beat

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

BHC reports after market close, meaning Day 0 captures anticipatory trading before results are released, while Day +1 represents the first full session where the market digests actual results.

Earnings Date Day 0 Move Day 0 Range Day +1 Move Day +1 Range
2026-07-29 +$0.16 (+3.54%) $0.23 (4.98%) +$1.35 (+28.85%) $1.10 (23.40%)
2026-04-29 -$0.08 (-1.41%) $0.20 (3.44%) +$0.13 (+2.33%) $0.58 (10.38%)
2026-02-18 +$0.20 (+3.34%) $0.36 (6.01%) -$0.26 (-4.20%) $0.79 (12.84%)
2025-10-29 -$0.29 (-4.68%) $0.33 (5.33%) +$0.71 (+12.03%) $0.80 (13.64%)
2025-07-30 -$0.43 (-6.30%) $0.54 (7.92%) -$0.50 (-7.82%) $0.51 (7.98%)
2025-04-30 -$0.21 (-3.81%) $0.24 (4.36%) +$0.00 (+0.00%) $0.34 (6.42%)
2025-02-19 +$0.15 (+2.36%) $0.25 (4.01%) +$0.67 (+10.29%) $0.53 (8.14%)
2024-10-30 +$0.01 (+0.12%) $0.31 (3.86%) +$1.03 (+12.61%) $0.90 (11.02%)
Avg Abs Move 3.20% 4.99% 9.77% 11.73%

Historical price action around BHC earnings shows dramatic post-announcement volatility, with Day +1 moves averaging 9.77% in absolute terms and ranging as wide as 11.73% on average. Day 0 moves are more muted at 3.20% average absolute movement, consistent with after-hours reporting where most reaction occurs the following session.

The most extreme reaction came after Q2 2026 results, when the stock surged +28.85% on Day +1 following the massive earnings beat—the largest single-day move in the dataset. Other notable Day +1 reactions include +12.61% (Q2 2025), +12.03% (Q3 2025), and +10.29% (Q1 2025), all following earnings beats. Conversely, the Q2 2025 miss triggered a -7.82% Day +1 decline.

The data reveals asymmetric risk: strong beats generate explosive upside moves exceeding 10%, while misses produce more contained 4-8% declines. This pattern suggests the market rewards positive surprises disproportionately, likely reflecting relief that the heavily-indebted company can execute operationally. With the stock's recent consolidation and estimate cuts heading into Q3, investors should anticipate high volatility in either direction based on whether results surprise.

Part 2.2: Options Market Expected Move

Metric Value
Expiration Date 10/30/26 (DTE 3)
Expected Move $0.18 (2.83%)
Expected Range $6.13 to $6.49
Implied Volatility 191.70%

The options market is pricing a 2.83% expected move through the October 30 expiration, significantly below the 9.77% average absolute Day +1 move observed historically. This suggests options traders are either underpricing earnings volatility or expecting a more muted reaction than BHC's recent history would indicate—particularly notable given the +28.85% explosion after last quarter's results.

Part 3: What Analysts Are Saying

Analysts maintain a Hold consensus on BHC with an average rating of 3.29 on the 5-point scale. The $7.58 mean price target implies 20% upside from the current $6.31 price level, with estimates ranging from a low of $6.50 to a high of $9.00.

The rating breakdown shows 1 Strong Buy, 0 Moderate Buys, 6 Holds, 0 Moderate Sells, and 0 Strong Sells across 7 analysts covering the stock. This distribution reflects cautious optimism—no one is outright bearish, but the overwhelming Hold weighting suggests analysts want more proof of sustainable execution before upgrading.

Sentiment has remained unchanged over the past month, with the average recommendation holding steady at 3.29 and the same 7-analyst count. This stability comes despite the strong Q2 beat, indicating analysts are waiting for confirmation that the outperformance can be repeated rather than rushing to upgrade based on a single quarter.

The 20% implied upside to the mean target is meaningful but not overwhelming, particularly given BHC's volatility profile. The wide target range—from $6.50 (just 3% upside) to $9.00 (43% upside)—reflects significant disagreement about the company's trajectory. Bulls see the cash flow generation and operational improvements as undervalued; bears remain concerned about the debt burden and execution consistency. The upcoming earnings report could be a catalyst to narrow this range if results provide clearer directional signals.

Part 4: Technical Picture

BHC enters earnings with strengthening technical momentum after a period of consolidation. The Barchart Technical Opinion currently shows a Buy signal at 88%, up sharply from 72% one week ago and 24% one month ago—indicating accelerating bullish momentum heading into the release.

Timeframe Analysis:

  • Short-term (50% Buy): Moderate buy signal suggests near-term momentum is positive but not overwhelming, reflecting recent consolidation around the $6.30 level
  • Medium-term (100% Buy): Strong buy signal indicates solid intermediate-term momentum as the stock has built a base above key moving averages
  • Long-term (100% Buy): Strong buy signal reflects the sustained uptrend from the $4.33 52-week low, with the stock up significantly over the past year

Trend Characteristics: The Average strength and Average direction suggest a steady, measured uptrend rather than an overheated rally—a constructive setup that provides room for upside on positive results without extreme overbought conditions.

The stock is trading at $6.31, positioned above its 20-day ($6.13), 50-day ($6.17), 100-day ($5.71), and 200-day ($5.69) moving averages, but below its 5-day ($6.41) and 10-day ($6.33) averages. This configuration shows strong intermediate and long-term support with recent short-term consolidation—a healthy technical pattern that suggests the stock is digesting gains rather than breaking down.

Period Value Period Value
5-Day MA $6.41 50-Day MA $6.17
10-Day MA $6.33 100-Day MA $5.71
20-Day MA $6.13 200-Day MA $5.69

Key resistance sits at the recent $6.41 level (5-day MA), while support is well-established at the $6.13-$6.17 zone (20-day and 50-day MAs). The stock's position in the upper half of its 52-week range ($4.33-$8.00) provides room for upside on a positive surprise, while the layered moving average support below suggests downside may be cushioned on disappointment. The overall technical setup is supportive heading into earnings, with improving momentum indicators and a constructive trend structure that could amplify a positive reaction while providing some technical floor on weakness.

This article was generated using Barchart’s automated content technology and existing data APIs. As a result, we are able to provide readers with timely, actionable, in-depth analysis on more equities, allowing them to make more informed decisions. All information and data in this article is solely for informational purposes. For more information, please view the Barchart Disclosure Policy here. And, if you would like to report any inaccuracies, please contact news@barchart.com.